Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
Neuroscience|October 6, 2007
Microinjection of the preferential dopamine receptor D3 agonist 7-hydroxy-N,N-di-n-propylaminotetralin hydrobromide into the hypothalamic medial preoptic area induced ejaculation in anesthetized ratsN D Kitrey, P Clément, J Bernabé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 30, 2005
[ATR-X syndrome: a new mutation in the XNP/ATRX gene near the helicase domain]F Giuliano, C Badens, C Richelme, et al.
International Journal of Clinical Practice|November 11, 2009
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety databaseF Giuliano, G Jackson, F Montorsi, et al.
The Italian Journal of Biochemistry|March 1, 1975
Human erythrocyte glucose 6-phosphate dehydrogenase. Influence of coenzyme derivatives on thermostability and kinetic propertiesA De Flora, A Morelli, F Giuliano, et al.
Computer Applications in the Biosciences : CABIOS|December 1, 1993
Potentially functional regions of nucleic acids recognized by a Kohonen's self-organizing mapF Giuliano, P Arrigo, F Scalia, et al.
The Journal of Urology|November 24, 1999
Assessment of the functional role of accessory pudendal arteries in erection by transrectal color Doppler ultrasoundS Droupy, A Hessel, G Benoît, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 19, 2001
Vaginal physiological changes in a model of sexual arousal in anesthetized ratsF Giuliano, J Allard, S Compagnie, et al.
Presse Medicale (Paris, France : 1983)|October 29, 1994
[Erection disorders: efficacy and tolerability after 6 months of intracavernous self-injections of alprostadil. Groupe Français d'Etude de l'Alprostadil]F Giuliano, P Blanchet, O Banzet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 19, 2010
[Treatment of the lower urinary tract symptoms secondary to benign prostatic hyperplasia by phosphodiesterase type 5 inhibitors. Review article]R Caremel, S Oger-Roussel, D Behr-Roussel, et al.
International Journal of Clinical Practice|July 2, 2011
Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse eventsV Mirone, A Sessa, F Giuliano, et al.
Pageof 16